帕金森病中的深度大脑刺激:打开/关闭dystonia的开关
Valeria Lo Faso1, Luigi Schisano2, Luigi Gianmaria Remore1
1Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
World neurosurgery
|November 19, 2024
概括
帕金森病的深度大脑刺激 (DBS) 可以改善先前存在的非 dystonia. 然而,在某些患者中,DBS也可能引发新的静脉,这可能与药物效应有关.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
背景情况:
- 抑郁症影响大约30%的帕金森病患者.
- 亚thalamic核深度大脑刺激 (DBS) 和 dystonia 之间的关系尚未完全理解.
研究的目的:
- 为了调查帕金森病患者的 dystonia 的原因.
- 为了澄清 dystonia 和双边亚thalamic 核 DBS 之间的联系.
主要方法:
- 从80名帕金森病患者的临床数据进行了回顾性分析.
- 评估之前和之后的 dystonia 症状 亚体内核 DBS.
- 评估与药物状态相关的 dystonia (在 dystonia / 脱离 dystonia).
主要成果:
- 在DBS后,非静脉缩症的康复率 (43.5%) 显著高于在静脉缩症 (9.1%) 的康复率.
- 大多数患者 (74.4%) 在外科手术后首次患上静脉 dystonia.
- 在DBS后发生在线静脉炎的患者在手术前服用较高的乐伏多巴剂量.
结论:
- 脑下细胞核DBS可以导致在手术前经历非静脉的患者的改善.
- DBS可能起到"附加增强"的作用,可能使条状状通路敏感,并在易受影响的个体中诱导on-dystonia.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
10.9K
相关概念视频
01:24Parkinson's Disease: Treatment
222
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482